benefitsCannabis newsgovermentlegallegalisingmarijuanaMedical Cannabisrecreational cannabisspanishstateukunited kingdomweed

Spanish Government to examine benefits of legalising medical cannabis

More recently, access has been opening up in France and the UK, with a trial access scheme underway in France and an increasing number of patients obtaining cannabis medication in the UK, as registered by ProjectTwenty21 and the new NHS registry of cannabis patients.

While Spain was among the first countries in Europe to decriminalise the personal use of cannabis, regulations on medical cannabis are trailing behind much of western and central Europe. Outdated laws around access to medical cannabis are still preventing patients from obtaining legal medical products other than a limited set of pharmaceutical cannabinoid products such as Sativex and Epydiolex. This is despite the fact that over 90% of the public support the legalisation of medical cannabis in Spain according to a recent survey by the Center for Sociological Research.

Today, the committee of the Spanish Congress voted in favour of a proposal filed by the Grupo Parlamentario Vasco (Basque Parliamentary Group), with the support of several groups, including the Observatario España de Cannabis Medicinal (Spanish Medicinal Cannabis Observer). The proposal, which was voted in by a majority of 20 votes in favour versus 14 against, establishes a subcommittee which will investigate the effects of regulated medical cannabis systems in other countries. The stated aims include ‘Giving a voice and listening to experiences of others and to everything that can enrich our own reflection: the legal bases, scientific evidence and technical difficulties for its implementation (of medical cannabis access)’.

The proposal was filed subsequent to a statement by the Spanish government that ‘the decision to create programmes for the use of cannabis for therapeutic purposes in Spain will be taken, where appropriate, weighing the evidence that exists on its effectiveness of therapeutic treatment and the adverse effects of the use of cannabis’.

The new subcommittee has the following formal purposes:

  • To analyse the experiences of other governments that have regulated medical cannabis access schemes. This will be completed with the input of foreign government personnel and other experts in the field.


  • To produce a report with proposals for the best practices in the control of medical cannabis in Spain. The report will be completed and presented by the subcommittee within six months of the initiation of the project. The report will be appraised by the Health and Consumer Affairs Commission before being sent for further consideration to the Spanish Congress.

A copy of the official proposal is available here, in Spanish.

As such, the creation of the subcommittee represents an important first step in the liberalisation of medical cannabis by the Spanish government. This move could open up the path to medical cannabis access in Spain in the coming years. The country currently remains as the largest country in Europe without some form of medical cannabis access.

Source: Prohibitionpartners

Image: Unsplashed

Source link

Related Articles

Back to top button